全文获取类型
收费全文 | 1417篇 |
免费 | 98篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 110篇 |
妇产科学 | 14篇 |
基础医学 | 138篇 |
口腔科学 | 66篇 |
临床医学 | 162篇 |
内科学 | 256篇 |
皮肤病学 | 15篇 |
神经病学 | 38篇 |
特种医学 | 276篇 |
外科学 | 86篇 |
综合类 | 27篇 |
预防医学 | 64篇 |
眼科学 | 9篇 |
药学 | 65篇 |
中国医学 | 1篇 |
肿瘤学 | 206篇 |
出版年
2021年 | 10篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 25篇 |
2017年 | 17篇 |
2016年 | 17篇 |
2015年 | 30篇 |
2014年 | 38篇 |
2013年 | 27篇 |
2012年 | 31篇 |
2011年 | 44篇 |
2010年 | 55篇 |
2009年 | 30篇 |
2008年 | 40篇 |
2007年 | 62篇 |
2006年 | 54篇 |
2005年 | 46篇 |
2004年 | 31篇 |
2003年 | 34篇 |
2002年 | 31篇 |
2001年 | 22篇 |
2000年 | 27篇 |
1999年 | 24篇 |
1998年 | 63篇 |
1997年 | 75篇 |
1996年 | 81篇 |
1995年 | 50篇 |
1994年 | 41篇 |
1993年 | 43篇 |
1992年 | 19篇 |
1991年 | 23篇 |
1990年 | 23篇 |
1989年 | 51篇 |
1988年 | 48篇 |
1987年 | 34篇 |
1986年 | 37篇 |
1985年 | 37篇 |
1984年 | 14篇 |
1983年 | 17篇 |
1982年 | 14篇 |
1981年 | 17篇 |
1980年 | 15篇 |
1979年 | 9篇 |
1978年 | 9篇 |
1977年 | 23篇 |
1976年 | 12篇 |
1975年 | 7篇 |
1973年 | 7篇 |
1971年 | 8篇 |
1966年 | 13篇 |
排序方式: 共有1545条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer 总被引:2,自引:0,他引:2
J N Ingle J E Krook S J Green T P Kubista L K Everson D L Ahmann M N Chang H F Bisel H E Windschitl D I Twito 《Journal of clinical oncology》1986,4(2):178-185
A randomized clinical trial was performed to compare the efficacy of bilateral oophorectomy with that of tamoxifen at a dose of 10 mg twice daily in premenopausal women with metastatic breast cancer, and to examine the efficacy of each as a crossover treatment. Initial treatment responses were seen in ten of 27 patients (37%) treated with oophorectomy and seven of 26 patients (27%) treated with tamoxifen. The difference was not statistically significant. Crossover responses were seen in five of 15 patients (33%) treated with oophorectomy, including three responses in ten prior tamoxifen nonresponders; and two of 18 patients (11%) treated with tamoxifen. Time to progression distributions were not significantly different during initial treatment, and no significant differences in survival were noted. Thus, there was no overall disadvantage to the use of tamoxifen as opposed to oophorectomy as initial hormonal therapy, and a failure to respond to tamoxifen did not preclude a response to subsequent oophorectomy. Exploratory data analysis within subsets indicated consistent differential treatment effects in the visceral dominant patients. Of the 16 such patients treated with oophorectomy, eight (50%) experienced objective responses but there were no responses in the 14 patients treated with tamoxifen. In the nine visceral dominant crossover patients who had not responded to initial tamoxifen, three (33%) subsequently responded to oophorectomy. Time to progression distributions within the visceral dominant subset appeared to be better for the patients treated initially with oophorectomy. However, one must be very cautious in drawing conclusions from exploratory subset analyses, especially with the small sample size. Further studies would be required to test any hypothesis of differential organ site responsiveness. 相似文献
5.
6.
7.
8.
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献